Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $26.7200 (0.6%) ($26.0000 - $27.0392) on Thu. Sep. 8, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.21% (three month average) | RSI | 32 | Latest Price | $26.7200(0.6%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EYES declines -3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(7%) UUP(6%) ICLN(5%) ARKG(4%) ARKK(4%) | Factors Impacting EYES price | EYES will decline at least -2.605% in a week (0% probabilities). BND(-7%) BNDX(-5%) XLU(-4%) XLP(-4%) VCSH(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.605% (StdDev 5.21%) | Hourly BBV | 0 () | Intraday Trend | 1.8% | | | |
|
1 - 5 Day Possible Target | $16.68(-37.57%) | Resistance Level | $28.33 | 5 Day Moving Average | $27.09(-1.37%) | 10 Day Moving Average | $27.1(-1.4%) | 20 Day Moving Average | $28.33(-5.68%) | To recent high | -29.1% | To recent low | 5% | Market Cap | $8.535b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |